Free Consultation
(877) 746.4275
Case Alert: BEOVU Lawsuit
Our team of attorneys is currently investigating claims that BEOVU (brolucizumab-dbll) use may be associated with an increased risk of retinal vasculitis and/or retinal vascular occlusion.
BEOVU is prescribed to treat wet age-related macular degeneration (wet AMD). BEOVU is manufactured by Novartis Pharmaceuticals, Co. of Basel, Switzerland. The FDA first approved BEOVU for use in the US on October 7, 2019.
In June 2020, the FDA approved a label update for BEOVU, adding the new warning that "[r]etinal vasculitis and/or retinal vascular occlusions, typically in the presence of intraocular inflammations, have been reported following BEOVU injections."
Retinal vasculitis is an eye inflammation involving the retinal vessels. Its symptoms include:
Retinal vascular occlusion occurs when one of the blood vessels carrying blood to or from the retina becomes blocked. Its symptoms include:
If you or a loved one were prescribed BEOVU, then you may be eligible to participate in a lawsuit against BEOVU’s manufacturers and sellers. If you hire ASK LLP, we may seek the following damages for you:
CALL TODAY! If you have been prescribed BEOVU, you might be entitled to compensation. Call ASK LLP at (877) RING ASK (877-746-4275) for a free case evaluation.
When you get hurt after using a drug, you may not know what to do. After all, the pharmaceutical industry is a large and powerful one. We are here to help. Our experienced legal team has a strong track record of fighting—and winning—against big pharmaceutical companies. We have already successfully represented more than 15,000 clients who were injured by dangerous, defective drugs. If you hire us, know that we will fight tirelessly to get you the best possible result.
Have you been prescribed BEOVU?
Call ASK LLP today at:
(877) RING ASK / (877-746-4275) for a free case evaluation or fill out the form below.
Easy. Quick. Confidential